Parkman Healthcare Partners’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-50,000
Closed -$1.32M 98
2020
Q3
$1.32M Buy
+50,000
New +$1.17M 0.35% 68

Other funds holding INOV

Parkman Healthcare Partners's INOV Position: Q4 2020 in Review

Parkman Healthcare Partners sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2020, closing a stake of 50,000 shares — an estimated $1.32M sold.

Parkman Healthcare Partners first reported a position in INOV in Q3 2020 and held it in 1 quarter. The position peaked at $1.32M in Q3 2020. 174 funds tracked by Wall St. Rank hold INOV as of Q4 2020.

  • Parkman Healthcare Partners reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Parkman Healthcare Partners sold 50,000 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2020, an estimated $1.32M.
  • Parkman Healthcare Partners first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q3 2020 and held it in 1 quarter.
  • Parkman Healthcare Partners's Inovalon Holdings, Inc. Class A Common Stock position peaked at $1.32M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2020.

Based on Parkman Healthcare Partners's 13F filing for Q4 2020, filed 12 Feb 2021.